Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Opthea Limited

OPT.AXASX
Healthcare
Biotechnology
$0.60
$0.00(0.00%)
Australian Market opens in 5h 43m

Opthea Limited Fundamental Analysis

Opthea Limited (OPT.AX) shows weak financial fundamentals with a PE ratio of -2.12, profit margin of -1014.12%, and ROE of 1.32%. The company generates $0.0B in annual revenue with weak year-over-year growth of -79.95%.

Key Strengths

PEG Ratio-0.05

Areas of Concern

ROE1.32%
Operating Margin-610.42%
Current Ratio0.22
We analyze OPT.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -76085.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-76085.7/100

We analyze OPT.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPT.AX struggles to generate sufficient returns from assets.

ROA > 10%
-4.32%

Valuation Score

Excellent

OPT.AX trades at attractive valuation levels.

PE < 25
-2.12
PEG Ratio < 2
-0.05

Growth Score

Moderate

OPT.AX shows steady but slowing expansion.

Revenue Growth > 5%
-79.95%
EPS Growth > 10%
62.86%

Financial Health Score

Moderate

OPT.AX shows balanced financial health with some risks.

Debt/Equity < 1
-1.23
Current Ratio > 1
0.22

Profitability Score

Weak

OPT.AX struggles to sustain strong margins.

ROE > 15%
132.37%
Net Margin ≥ 15%
-1014.12%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPT.AX Expensive or Cheap?

P/E Ratio

OPT.AX trades at -2.12 times earnings. This suggests potential undervaluation.

-2.12

PEG Ratio

When adjusting for growth, OPT.AX's PEG of -0.05 indicates potential undervaluation.

-0.05

Price to Book

The market values Opthea Limited at -2.58 times its book value. This may indicate undervaluation.

-2.58

EV/EBITDA

Enterprise value stands at -1.82 times EBITDA. This is generally considered low.

-1.82

How Well Does OPT.AX Make Money?

Net Profit Margin

For every $100 in sales, Opthea Limited keeps $-1014.12 as profit after all expenses.

-1014.12%

Operating Margin

Core operations generate -610.42 in profit for every $100 in revenue, before interest and taxes.

-610.42%

ROE

Management delivers $1.32 in profit for every $100 of shareholder equity.

1.32%

ROA

Opthea Limited generates $-4.32 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.32%

Following the Money - Real Cash Generation

Operating Cash Flow

Opthea Limited generates limited operating cash flow of $-133.86M, signaling weaker underlying cash strength.

$-133.86M

Free Cash Flow

Opthea Limited generates weak or negative free cash flow of $-133.86M, restricting financial flexibility.

$-133.86M

FCF Per Share

Each share generates $-0.10 in free cash annually.

$-0.10

FCF Yield

OPT.AX converts -20.96% of its market value into free cash.

-20.96%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.12

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.05

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.58

vs 25 benchmark

P/S Ratio

Price to sales ratio

2386.48

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.23

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.22

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.32

vs 25 benchmark

ROA

Return on assets percentage

-4.32

vs 25 benchmark

ROCE

Return on capital employed

0.73

vs 25 benchmark

How OPT.AX Stacks Against Its Sector Peers

MetricOPT.AX ValueSector AveragePerformance
P/E Ratio-2.1228.25 Better (Cheaper)
ROE132.37%780.00% Weak
Net Margin-101412.03%-20122.00% (disorted) Weak
Debt/Equity-1.230.30 Strong (Low Leverage)
Current Ratio0.224.66 Weak Liquidity
ROA-431.78%-14687.00% (disorted) Weak

OPT.AX outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Opthea Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-96.36%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-114.84%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-309.31%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ